fashion -WSS

fashion

author：fashion 2025-09-14 21:55:53 - browse：28

An interface with a wire frame human on the center left, a human brain on the top right, a microscope on the bottom left, and some codes on both sides — coverage from STAT — Adobe

If the past year was prelude, the U.S. government in 2024 is poised to re-write the rules surrounding the use of artificial intelligence in health care.

Just in the past few months, President Joe Biden ordered a sweeping crackdown on AI by federal health agencies; members of Congress promised to step up oversight and pass new legislation; and many AI experts, from within industry and outside of it, sounded alarms about the urgent need for standards.

The heightened scrutiny is driven by rapid advances of generative AI tools such as ChatGPT. But makers of all kinds of predictive models may, for the first time, be required to explain how their systems were developed and tested — and prove that they are safe, reliable, and fair.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： The dental labor crisis is a moment of opportunity

WSS

As obesity drug market grows, telehealth companies court payers

Doctors' information doesn't help them choose wisely when sick

National associations that represent hospice owe an apology

PhRMA lawsuit over Medicare drug price negotiation tossed

Gilead might be held responsible for not developing a drug

Doctors' information doesn't help them choose wisely when sick

focus

fashion

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Cancer drug shortages should be causing more outrage

Roche's accidental data boosts hopes for anti

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Listen: Vivek Ramaswamy's star turn & leaky drug data

DIEP, the 'gold standard' of breast reconstruction, is under threat

How the first Native Hawaiian psychiatrist helped diversify medicine

Sports medicine is finally prioritizing gender equality

Vaccine advisory panel ACIP left half staffed by HHS

focus

Vivek Ramaswamy made waves in the debate, much as in biotech

Medicare Advantage proposed rates disappoint insurers

What we’ve learned from the Aduhelm mess

How digital tools helped lower hypertension in marginalized patients

A disappointing year of Humira biosimilars

FDA advisory panel to debate high blood pressure devices

explore

focus

knowledge

Wikipedia